BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference.ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BRLI BRLI Bio Rad Laboratories Inc ) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the 2009 UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Global Life Sciences Conference on Monday, September 21, 2009, at The Grand Hyatt Hotel located in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY. The BioReference Laboratories presentation is scheduled to begin at 8:00 a.m. Eastern Daylight Time. Those wishing to listen to the live audio webcast may access it on the Company's corporate web site, www.bioreference.com. Please go to the site ten minutes before the presentation is ready to begin. You will need to register as well as download and install any necessary audio software. The webcast will be archived on the BioReference website for 30 days following the call. About BioReference Laboratories, Inc. BRLI is the third largest full service laboratory in the United States and the largest independent regional laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostics, anatomical pathology anatomical pathology n. The study of the structural and compositional changes that occur in organs and tissues as a result of disease. Also called pathological anatomy. and correctional health care. BRLI operates as a national oncology laboratory under its GenPath label. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. BRLI's innovative technology platform for sexually transmitted infections has enabled it to expand as a national laboratory in the area of Women's Health. GeneDx, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH CGH Comparative Genomic Hybridization CGH Changi General Hospital (Singapore) CGH Computer-Generated Hologram CGH Community General Hospital (Syracuse, NY) array platform and its NextGen sequence offerings that are currently offered in cardiology and will be offered in the future in other disease specific areas. www.bioreference.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion